Viral Vectors And Plasmid DNA Global Market Report 2022 – By Product (Plasmid DNA, Viral Vectors), By Application (Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development), By Disease (Infectious Diseases, Genetic Disorders, Cancer), By End User (Research Institutes, Biopharmaceutical And Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 150 | Published : February 2022 | SKU CODE : 7569 | Delivery Time: 2-3 business days | Format :


The viral vectors & plasmid DNA market consists of sales of viral vectors and plasmid DNA and related services. The viral vectors & plasmid DNA are used for the delivery of cellular therapies, like gene therapy and immunotherapy, and also for treating some viral infections. The viral vectors & plasmid DNA are used for formulation development in research and development labs. The viral vectors are genetically engineered viruses carrying viral RNA or DNA that is non-infectious but still contain viral promoters and transgene. The plasmid DNA is a double-stranded extrachromosomal and circular DNA sequence that is capable of replication using the host cell's replication system.

The main types of products in viral vectors & plasmid DNA are plasmid DNA and viral vectors. A plasmid is a single-stranded, circular DNA molecule which is different from the chromosomal DNA of a cell. Plasmids are found organically in bacterial cells as well as in certain eukaryotes. Plasmid genes frequently confer genetic benefits to bacteria, such as antibiotic resistance. The different diseases include infectious diseases, genetic disorders, cancer, others and is used in gene and cancer therapies, viral infections, immunotherapy, formulation development, others. The several sectors include research institutes, biopharmaceutical and pharmaceutical companies.

The global viral vectors & plasmid DNA market size is expected to grow from $0.69 billion in 2021 to $0.80 billion in 2022 at a compound annual growth rate (CAGR) of 14.8%. The growth in the market is mainly due to the outbreak of COVID-19 and requires targeted delivery of the drug to treat affected patients. The number of cases has been increasing resulting in a surge in demand for viral vectors & plasmid DNA. The viral vectors and plasmid DNA market is expected to reach $1.38 billion in 2026 at a CAGR of 14.8%.

The rise in the global incidence of cancer is driving the viral vector & plasmid DNA market. The major causes for most cancers include obesity, smoking, alcohol, improper eating habits. According to American cancer society 2020, an estimated 1.8 million new cancer cases diagnosed and 606,520 cancer deaths in the United States. Furthermore, according to the American Cancer Society, in 2019, around 606,880 deaths were caused in USA due to prevalence of the cancer. The Cancer Research UK predicts that there will be 27.5 million new cases of cancer each year by 2040. The rise in the global incidence of cancer is expected to boost the demand for the viral vectors and plasmid DNA market over coming years.

The unaffordable cost of gene therapies is a major challenge in the viral vectors & plasmid DNA market. The prices of gene therapies range between $0.2 million to $2.1 million. For instance, Gilead company's Yescarta is a gene therapy that costs around $0.3 million and Bluebird Bio's Letiglobin is another gene therapy costing around $2.1 million. The high price is due to various factors like government regulations, production costs, and so on. Therefore, the unaffordable cost of gene therapies is limiting the viral vector & plasmid DNA market growth.

In January 2020, Cognate Bioservices Inc, a US-based company skilled in cell and cell-mediated gene therapy products, acquired Cobra Biologics, specialized in providing manufacturing services for plasmid DNA and viral vector, for an undisclosed amount. The acquisition is expected to create a platform for the life cycle management of cell and gene therapy products. Cobra biologics is well established in the development and manufacture of a variety of viral vectors and DNA. The combined Cognate and Cobra expertise is expected to push both the businesses to a better position to respond to current and future market demand.

Major players in the viral vectors & plasmid DNA market are FUJIFILM Diosynth Biotechnologies, FinVector Vision Therapies, Lonza, Cobra Biologics and Pharmaceutical Services, Brammer Bio, ??n?k? ??r??r?t??n, Cell and Gene Therapy Catapult, VGXI and MassBiologics.

North America is the largest region in the iral vectors and plasmid DNA market in 2021. The Middle East is expected to be the fastest growing region. The regions covered in the viral vectors & plasmid DNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the viral vectors & plasmid DNA market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global viral vectors and plasmid DNA market is segmented -

1) By Product: Plasmid DNA, Viral Vectors

2) By Application: Gene and Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Others

3) By Disease: Infectious Diseases, Genetic Disorders, Cancer, Others

4) By End-User: Research Institutes, Biopharmaceutical and Pharmaceutical Companies

    Table Of Contents

    1. Executive Summary

    2. Viral Vectors & Plasmid DNA Market Characteristics

    3. Viral Vectors & Plasmid DNA Market Trends And Strategies

    4. Impact Of COVID-19 On Viral Vectors & Plasmid DNA

    5. Viral Vectors & Plasmid DNA Market Size And Growth

    5.1. Global Viral Vectors & Plasmid DNA Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Viral Vectors & Plasmid DNA Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Viral Vectors & Plasmid DNA Market Segmentation

    6.1. Global Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Plasmid DNA

    Viral Vectors

    6.2. Global Viral Vectors & Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Gene And Cancer Therapies

    Viral Infections

    Immunotherapy

    Formulation Development

    Others

    6.3. Global Viral Vectors & Plasmid DNA Market, Segmentation By Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Infectious Diseases

    Genetic Disorders

    Cancer

    Others

    6.4. Global Viral Vectors & Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Research Institutes

    Biopharmaceutical and Pharmaceutical Companies

    7. Viral Vectors & Plasmid DNA Market Regional And Country Analysis

    7.1. Global Viral Vectors & Plasmid DNA Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Viral Vectors & Plasmid DNA Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Viral Vectors & Plasmid DNA Market

    8.1. Asia-Pacific Viral Vectors & Plasmid DNA Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.3. Asia-Pacific Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Viral Vectors & Plasmid DNA Market

    9.1. China Viral Vectors & Plasmid DNA Market Overview

    9.2. China Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    9.3. China Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Viral Vectors & Plasmid DNA Market

    10.1. India Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.2. India Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Viral Vectors & Plasmid DNA Market

    11.1. Japan Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.2. Japan Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Viral Vectors & Plasmid DNA Market

    12.1. Australia Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.2. Australia Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Viral Vectors & Plasmid DNA Market

    13.1. Indonesia Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.2. Indonesia Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Viral Vectors & Plasmid DNA Market

    14.1. South Korea Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.2. South Korea Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Viral Vectors & Plasmid DNA Market

    15.1. Western Europe Viral Vectors & Plasmid DNA Market Overview

    15.2. Western Europe Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.3. Western Europe Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Viral Vectors & Plasmid DNA Market

    16.1. UK Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.2. UK Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Viral Vectors & Plasmid DNA Market

    17.1. Germany Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.2. Germany Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Viral Vectors & Plasmid DNA Market

    18.4. France Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.5. France Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Viral Vectors & Plasmid DNA Market

    19.1. Eastern Europe Viral Vectors & Plasmid DNA Market Overview

    19.2. Eastern Europe Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.3. Eastern Europe Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Viral Vectors & Plasmid DNA Market

    20.1. Russia Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.2. Russia Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Viral Vectors & Plasmid DNA Market

    21.1. North America Viral Vectors & Plasmid DNA Market Overview

    21.2. North America Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.3. North America Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Viral Vectors & Plasmid DNA Market

    22.1. USA Viral Vectors & Plasmid DNA Market Overview

    22.2. USA Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.3. USA Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Viral Vectors & Plasmid DNA Market

    23.1. South America Viral Vectors & Plasmid DNA Market Overview

    23.2. South America Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.3. South America Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Viral Vectors & Plasmid DNA Market

    24.1. Brazil Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.2. Brazil Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Viral Vectors & Plasmid DNA Market

    25.1. Middle East Viral Vectors & Plasmid DNA Market Overview

    25.2. Middle East Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25.3. Middle East Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Viral Vectors & Plasmid DNA Market

    26.1. Africa Viral Vectors & Plasmid DNA Market Overview

    26.2. Africa Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26.3. Africa Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Viral Vectors & Plasmid DNA Market Competitive Landscape And Company Profiles

    27.1. Viral Vectors & Plasmid DNA Market Competitive Landscape

    27.2. Viral Vectors & Plasmid DNA Market Company Profiles

    27.2.1. FUJIFILM Diosynth Biotechnologies

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. FinVector Vision Therapies

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Lonza

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Cobra Biologics and Pharmaceutical Services

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Brammer Bio

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Viral Vectors & Plasmid DNA Market

    29. Viral Vectors & Plasmid DNA Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Viral Vectors & Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Viral Vectors & Plasmid DNA Market, Segmentation By Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Viral Vectors & Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Viral Vectors & Plasmid DNA Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Global Viral Vectors & Plasmid DNA Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Asia-Pacific, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: Asia-Pacific, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: China, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: China, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: India, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: India, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Japan, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: Japan, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Australia, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: Australia, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Indonesia, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: Indonesia, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: South Korea, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: South Korea, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: Western Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: Western Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: UK, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: UK, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: Germany, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28: Germany, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 29: France, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 30: France, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 31: Eastern Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 32: Eastern Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 33: Russia, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 34: Russia, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 35: North America, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 36: North America, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 37: USA, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 38: USA, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 39: South America, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 40: South America, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 41: Brazil, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 42: Brazil, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 43: Middle East, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 44: Middle East, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 45: Africa, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 46: Africa, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 47: FUJIFILM Diosynth Biotechnologies Financial Performance
  • Table 48: FinVector Vision Therapies Financial Performance
  • Table 49: Lonza Financial Performance
  • Table 50: Cobra Biologics and Pharmaceutical Services Financial Performance
  • Table 51: Brammer Bio Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Viral Vectors & Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Viral Vectors & Plasmid DNA Market, Segmentation By Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Viral Vectors & Plasmid DNA Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Viral Vectors & Plasmid DNA Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Global Viral Vectors & Plasmid DNA Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Asia-Pacific, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: Asia-Pacific, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: China, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: China, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: India, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: India, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: Japan, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: Japan, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Australia, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: Australia, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Indonesia, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: Indonesia, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: South Korea, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: South Korea, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: Western Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: Western Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: UK, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: UK, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: Germany, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 28: Germany, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 29: France, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 30: France, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 31: Eastern Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 32: Eastern Europe, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 33: Russia, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 34: Russia, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 35: North America, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 36: North America, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 37: USA, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 38: USA, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 39: South America, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 40: South America, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 41: Brazil, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 42: Brazil, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 43: Middle East, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 44: Middle East, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 45: Africa, Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 46: Africa, Viral Vectors & Plasmid DNA Market, Segmentation By Applications, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 47: FUJIFILM Diosynth Biotechnologies Financial Performance
  • Figure 48: FinVector Vision Therapies Financial Performance
  • Figure 49: Lonza Financial Performance
  • Figure 50: Cobra Biologics and Pharmaceutical Services Financial Performance
  • Figure 51: Brammer Bio Financial Performance
Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Anti-Viral Drug Therapy Market - By Drug Class (DNA (Nucleotide) Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Application (HIV, Hepatitis, Herpes, Influenza), Anti-Viral Drug Therapy Market Size, Opportunities And Strategies - Global Anti-Viral Drug Therapy Market Forecast To 2030
View Report
Antivirals Global Market Report 2022 – By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Application (HIV, Hepatitis, Herpes, Influenza), By Type (Branded, Generic) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Gene Therapy Global Market Report 2022 – By Gene Type (Antigen, Cytokine, Suicide Gene), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases), By End Users (Hospitals, Homecare, Specialty Clinics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Cancer Biologics Global Market Report 2022 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy), By Application (Non-Small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers), By Distribution Channel (Hospitals, Clinics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Cellular Immunotherapy Global Market Report 2022 – By Therapy (Tumour-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumour, Lung Cancer) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Cancer Vaccines Global Market Report 2022 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
COVID-19 Drug Associated APIs Global Market Report 2022 – By Drug Class (Antimalarials, Bronchodilators, Antibiotics, Antivirals), By Source (Microorganisms, Animals, Plants), By Synthesis Type (Synthetic, Biotech), By Business Mode (Captive API, Merchant API) – Market Size, Trends, And Global Forecast 2022-2026
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)